These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36002447)

  • 21. The prognostic significance of attenuated psychotic symptoms in help-seeking youth.
    Hazan H; Spelman T; Amminger GP; Hickie I; McGorry PD; Phillips LJ; Purcell R; Wood SJ; Yung AR; Nelson B
    Schizophr Res; 2020 Jan; 215():277-283. PubMed ID: 31615738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Checking the predictive accuracy of basic symptoms against ultra high-risk criteria and testing of a multivariable prediction model: Evidence from a prospective three-year observational study of persons at clinical high-risk for psychosis.
    Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
    Eur Psychiatry; 2017 Sep; 45():27-35. PubMed ID: 28728092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adolescents at ultra-high risk of psychosis in Italian neuropsychiatry services: prevalence, psychopathology and transition rate.
    Pelizza L; Azzali S; Garlassi S; Paterlini F; Scazza I; Chiri LR; Pupo S; Raballo A
    Eur Child Adolesc Psychiatry; 2018 Jun; 27(6):725-737. PubMed ID: 29058115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Attenuated psychosis syndrome: A new diagnostic category for further study in DSM-5].
    Samiotakis G; Kollias C; Lazaratou H; Anagnostopoulos D; Kontaxakis V
    Psychiatriki; 2017; 28(2):120-130. PubMed ID: 28686559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of metacognitive beliefs in the proneness to hallucinations and delusions: an analysis across clinical and non-clinical populations.
    Goldstone E; Farhall J; Thomas N; Ong B
    Br J Clin Psychol; 2013 Sep; 52(3):330-46. PubMed ID: 23865408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (Attenuated) hallucinations join basic symptoms in a transdiagnostic network cluster analysis.
    Jimeno N; Gomez-Pilar J; Poza J; Hornero R; Vogeley K; Meisenzahl E; Lichtenstein TK; Rosen M; Kambeitz J; Klosterkötter J; Schultze-Lutter F
    Schizophr Res; 2022 May; 243():43-54. PubMed ID: 35231833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baseline grey matter volume of non-transitioned "ultra high risk" for psychosis individuals with and without attenuated psychotic symptoms at long-term follow-up.
    Cropley VL; Lin A; Nelson B; Reniers RLEP; Yung AR; Bartholomeusz CF; Klauser P; Velakoulis D; McGorry P; Wood SJ; Pantelis C
    Schizophr Res; 2016 Jun; 173(3):152-158. PubMed ID: 26032566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic and Prognostic Significance of Brief Limited Intermittent Psychotic Symptoms (BLIPS) in Individuals at Ultra High Risk.
    Fusar-Poli P; Cappucciati M; De Micheli A; Rutigliano G; Bonoldi I; Tognin S; Ramella-Cravaro V; Castagnini A; McGuire P
    Schizophr Bull; 2017 Jan; 43(1):48-56. PubMed ID: 28053130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basic symptoms influence real-life functioning and symptoms in individuals at high risk for psychosis.
    Glenthøj LB; Bailey B; Kristensen TD; Wenneberg C; Hjorthøj C; Nordentoft M
    Acta Psychiatr Scand; 2020 Mar; 141(3):231-240. PubMed ID: 31621062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interrelationship between schizotypy, clinical high risk for psychosis and related symptoms: Cognitive disturbances matter.
    Flückiger R; Michel C; Grant P; Ruhrmann S; Vogeley K; Hubl D; Schimmelmann BG; Klosterkötter J; Schmidt SJ; Schultze-Lutter F
    Schizophr Res; 2019 Aug; 210():188-196. PubMed ID: 30683524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Frankfurt Complaint Questionnaire for self-assessment of basic symptoms in the early detection of psychosis-Factor structure, reliability, and predictive validity.
    Uttinger M; Studerus E; Ittig S; Heitz U; Schultze-Lutter F; Riecher-Rössler A
    Int J Methods Psychiatr Res; 2018 Jun; 27(2):e1600. PubMed ID: 29266529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Attenuated Psychosis Syndrome and Facial Affect Processing in Adolescents With and Without Autism.
    Maat A; Therman S; Swaab H; Ziermans T
    Front Psychiatry; 2020; 11():759. PubMed ID: 32848934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basic symptoms and gray matter volumes of patients at clinical high risk for psychosis.
    Hubl D; Michel C; Schultze-Lutter F; Hauf M; Schimmelmann BG; Kaess M; Kindler J
    Psychol Med; 2021 Nov; 51(15):2666-2674. PubMed ID: 32404212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the predictive power of the unspecific risk category of the Basel Screening Instrument for Psychosis.
    Peralta D; Studerus E; Andreou C; Beck K; Ittig S; Leanza L; Egloff L; Riecher-Rössler A
    Early Interv Psychiatry; 2019 Aug; 13(4):969-976. PubMed ID: 30019850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of distress related to attenuated psychotic symptoms in individuals at ultra high risk of psychosis: Findings from the Longitudinal Youth at Risk Study.
    Rekhi G; Rapisarda A; Lee J
    Early Interv Psychiatry; 2019 Feb; 13(1):73-78. PubMed ID: 28560723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uncovering the realities of delusional experience in schizophrenia: a qualitative phenomenological study in Belgium.
    Feyaerts J; Kusters W; Van Duppen Z; Vanheule S; Myin-Germeys I; Sass L
    Lancet Psychiatry; 2021 Sep; 8(9):784-796. PubMed ID: 34358475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic and Prognostic Significance of DSM-5 Attenuated Psychosis Syndrome in Services for Individuals at Ultra High Risk for Psychosis.
    Fusar-Poli P; De Micheli A; Cappucciati M; Rutigliano G; Davies C; Ramella-Cravaro V; Oliver D; Bonoldi I; Rocchetti M; Gavaghan L; Patel R; McGuire P
    Schizophr Bull; 2018 Feb; 44(2):264-275. PubMed ID: 28521060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of attenuated psychotic symptoms and their relationship with DSM-IV diagnoses in a general psychiatric outpatient clinic.
    Gaudiano BA; Zimmerman M
    J Clin Psychiatry; 2013 Feb; 74(2):149-55. PubMed ID: 23146173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of age and sex on clinical high-risk for psychosis in the community.
    Schultze-Lutter F; Schimmelmann BG; Flückiger R; Michel C
    World J Psychiatry; 2020 May; 10(5):101-124. PubMed ID: 32477906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sources of clinical distress in young people at ultra high risk of psychosis.
    Rapado-Castro M; McGorry PD; Yung A; Calvo A; Nelson B
    Schizophr Res; 2015 Jun; 165(1):15-21. PubMed ID: 25890793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.